Administration of semaglutide before metabolic and bariatric surgery does not confer benefits for overall weight loss, ...

Experts stress that obesity is a disease, not a lifestyle choice, and call for better access to pharmacological and surgical ...

A RETROSPECTIVE study conducted by Mass General Brigham researchers has found that taking semaglutide before bariatric ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

China’s obesity crisis is a sizeable profit opportunity. More than half of Chinese adults are overweight or obese — a figure expected to hit two-thirds by 2030. That is nearly 900mn people, a market ...

Semaglutide wasn't approved for obesity at higher doses until 2021, and therefore maximum weight-loss doses were often not reached by patients, Sheu's group pointed out. Also, since the cohort was ...

While some drugs have fallen off, more have been added: AbbVie recently jumped into the obesity craze by licensing an ...

Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.

As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market ...